Related Experiment Video
Updated: Jan 13, 2026
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Effect of probiotic strain, duration, and dose on preventing ICU-acquired infection: A scoping review
Aqdar Mufareh Al-Aklabi1, Sara Muteb Alotaishan2, Yasmin Youssuf Al-Gindan2
1Clinical Nutrition Department, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; Almana Medical Center, Al Rakah, Al Khobar, Saudi Arabia.
Background:
Intensive care unit-acquired infections (ICU-AIs) are prevalent among critically ill patients due to multiple invasive procedures. Probiotics have emerged as a potential preventive strategy to lower infection rates in ICU settings. However, studies assessing probiotic effectiveness have reported inconsistent results, suggesting that these discrepancies are due to variations in probiotic strain, intervention duration, and dosage. Despite the growing interest and the existence of several reviews, the optimal probiotic strain, duration, and dosage for ICU patients remain uncertain.
Objectives:
This review aims to assess the impact of strain specificity, intervention duration, and dosage on the effectiveness of probiotic supplementation in preventing ICU-AIs.
Methods:
This scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. A comprehensive search was conducted in electronic databases for English-language interventional and observational studies published between January 2014 and August 2024. Eligible studies were those that evaluated the efficacy of probiotics in reducing ICU-AIs. Data were extracted using a standardized form that included details on strain designation, intervention duration, and dosage. Findings were synthesized descriptively using narrative text, tables, and figures.
Results:
Eighteen different probiotic strains were identified. Lactobacillus acidophilus LA-5, particularly in multi-strain formulations, was commonly associated with positive outcomes. Probiotic regimens with intervention durations of 14 days or more and dosages of at least 5 × 10⁹ CFU/day demonstrated greater effectiveness in reducing ICU-AIs.
Conclusions:
Strain-specificity, intervention duration, and dosage are important factors influencing probiotic effectiveness in ICU-AI prevention. Further studies are needed to confirm the efficacy of promising strains and explore the potential of new ones.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
01:28Antimicrobial Effectiveness
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...